JAEGER WILFRED E
Insider CIK 1190474 · LPDX 10% owner · THLD Director, 10% owner · STIM Director · CNCE Director, 10% owner · ACRX 10% owner · NVRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STIM Neuronetics, Inc. | A Award | 2023-05-25 | 2023-05-30 | 36,364 | — | $0 | 138,563 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 10,250 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 5,125 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer | 2023-03-06 | 2023-03-06 | 16,400 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-06-09 | 2022-06-13 | 16,400 | — | $0 | 21,525 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2022-05-26 | 2022-05-31 | 38,910 | — | $0 | 102,187 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-06-10 | 2021-06-11 | 10,250 | — | $0 | 10,250 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2021-06-10 | 2021-06-11 | 5,125 | — | $0 | 5,125 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2021-05-27 | 2021-06-01 | 7,137 | — | $0 | 63,289 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2020-08-05 | 2020-08-07 | 18,513 | — | $0 | 56,152 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-06-11 | 2020-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2020-05-26 | 2020-05-28 | 20,000 | — | $0 | 37,639 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2020-05-21 | 2020-05-26 | 1,376 | — | $0 | 9,592 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2020-01-02 | 2020-01-06 | 3,062 | $4.49 | $13.7K | 17,639 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-10-01 | 2019-10-03 | 1,957 | $8.30 | $16.2K | 14,577 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-07-01 | 2019-07-02 | 1,298 | $12.51 | $16.2K | 12,620 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2019-06-13 | 2019-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| STIM Neuronetics, Inc. | A Award deriv | 2019-05-28 | 2019-05-30 | 7,347 | — | $0 | 7,347 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-05-28 | 2019-05-30 | 3,723 | — | $0 | 11,322 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2019-05-20 | 2019-05-22 | 2,913 | — | $0 | 8,216 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-04-01 | 2019-04-03 | 932 | $14.75 | $13.7K | 7,599 | SEC↗ |
| STIM Neuronetics, Inc. | A Award deriv | 2018-07-02 | 2018-07-05 | 8,767 | — | $0 | 8,767 | SEC↗ |
| STIM Neuronetics, Inc. | P Buy | 2018-07-02 | 2018-07-05 | 6,667 | $17.00 | $113.3K | 6,667 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 126,153 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 3,347,357 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 179,962 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 5,713,569 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2018-05-21 | 2018-05-23 | 3,785 | — | $0 | 5,303 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-07 | 2018-03-07 | 1,461 | $81.42 | $119.0K | 11,042 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-07 | 2018-03-07 | 66,125 | $81.42 | $5.38M | 500,109 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-06 | 2018-03-07 | 49,742 | $80.38 | $4.00M | 566,234 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-06 | 2018-03-07 | 1,098 | $80.38 | $88.3K | 12,503 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-05 | 2018-03-07 | 910 | $80.19 | $73.0K | 13,601 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-05 | 2018-03-07 | 41,206 | $80.19 | $3.30M | 615,976 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-01 | 2018-03-01 | 9,784 | $80.48 | $787.4K | 657,182 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-01 | 2018-03-01 | 216 | $80.48 | $17.4K | 14,511 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-28 | 2018-03-01 | 151 | $81.36 | $12.3K | 14,727 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-28 | 2018-03-01 | 6,832 | $81.36 | $555.9K | 666,966 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-28 | 2018-03-01 | 7,844 | $83.09 | $651.8K | 673,798 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-28 | 2018-03-01 | 173 | $83.09 | $14.4K | 14,878 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-27 | 2018-03-01 | 286 | $83.20 | $23.8K | 15,051 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-27 | 2018-03-01 | 12,972 | $83.20 | $1.08M | 681,642 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-27 | 2018-03-01 | 26 | $84.17 | $2.2K | 15,337 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-02-27 | 2018-03-01 | 1,174 | $84.17 | $98.8K | 694,614 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-09-14 | 2017-09-18 | 3,176 | $89.72 | $285.0K | 953,322 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-09-14 | 2017-09-18 | 70 | $89.72 | $6.3K | 21,050 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-09-14 | 2017-09-18 | 286 | $90.31 | $25.8K | 20,764 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-09-14 | 2017-09-18 | 12,935 | $90.31 | $1.17M | 940,387 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-24 | 2017-08-24 | 7,156 | $87.00 | $622.6K | 956,498 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-24 | 2017-08-24 | 158 | $87.00 | $13.7K | 21,120 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-23 | 2017-08-24 | 112 | $87.01 | $9.7K | 21,278 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-23 | 2017-08-24 | 5,094 | $87.01 | $443.2K | 963,654 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-22 | 2017-08-24 | 19,568 | $85.17 | $1.67M | 988,316 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-22 | 2017-08-24 | 432 | $86.48 | $37.4K | 21,390 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-22 | 2017-08-24 | 19,568 | $86.48 | $1.69M | 968,748 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-22 | 2017-08-24 | 432 | $85.17 | $36.8K | 21,822 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-21 | 2017-08-21 | 24,460 | $84.44 | $2.07M | 1,007,884 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-21 | 2017-08-21 | 540 | $84.44 | $45.6K | 22,254 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-17 | 2017-08-21 | 331 | $84.02 | $27.8K | 22,794 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-17 | 2017-08-21 | 15,012 | $84.02 | $1.26M | 1,032,344 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-16 | 2017-08-16 | 299 | $82.75 | $24.7K | 23,361 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-16 | 2017-08-16 | 236 | $84.04 | $19.8K | 23,125 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-16 | 2017-08-16 | 10,701 | $84.04 | $899.3K | 1,047,356 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-16 | 2017-08-16 | 13,501 | $82.75 | $1.12M | 1,058,057 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-15 | 2017-08-16 | 641 | $82.54 | $52.9K | 23,660 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-15 | 2017-08-16 | 29,024 | $82.54 | $2.40M | 1,071,558 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-14 | 2017-08-16 | 24,709 | $82.40 | $2.04M | 1,100,582 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-14 | 2017-08-16 | 546 | $82.40 | $45.0K | 24,301 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2017-05-25 | 2017-05-30 | 3,545 | — | $0 | 3,545 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2017-05-25 | 2017-05-30 | 1,518 | — | $0 | 1,518 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-03 | 2017-03-03 | 16 | $95.00 | $1.5K | 24,847 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-03 | 2017-03-03 | 703 | $95.00 | $66.8K | 1,125,291 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-02 | 2017-03-03 | 6 | $95.00 | $570 | 24,863 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-02 | 2017-03-03 | 294 | $95.00 | $27.9K | 1,125,994 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-01 | 2017-03-03 | 928 | $95.03 | $88.2K | 24,869 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-01 | 2017-03-03 | 42,033 | $95.03 | $3.99M | 1,126,288 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-22 | 2016-08-22 | 6,217 | $98.58 | $612.9K | 1,171,888 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-22 | 2016-08-22 | 3,567 | $99.89 | $356.3K | 1,168,321 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-22 | 2016-08-22 | 137 | $98.58 | $13.5K | 25,876 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-22 | 2016-08-22 | 79 | $99.89 | $7.9K | 25,797 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-19 | 2016-08-22 | 1,034 | $97.86 | $101.2K | 26,383 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-19 | 2016-08-22 | 46,843 | $97.86 | $4.58M | 1,194,858 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-19 | 2016-08-22 | 16,753 | $98.30 | $1.65M | 1,178,105 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-19 | 2016-08-22 | 370 | $98.30 | $36.4K | 26,013 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 216 | $96.88 | $20.9K | 28,926 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 66,066 | $97.53 | $6.44M | 1,243,951 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 1,459 | $97.53 | $142.3K | 27,467 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 50 | $98.14 | $4.9K | 27,417 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 2,250 | $98.14 | $220.8K | 1,241,701 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-18 | 2016-08-22 | 9,799 | $96.88 | $949.3K | 1,310,017 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-17 | 2016-08-17 | 661 | $96.16 | $63.6K | 29,142 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-17 | 2016-08-17 | 29,953 | $96.16 | $2.88M | 1,319,816 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-16 | 2016-08-17 | 73 | $97.06 | $7.1K | 29,803 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-16 | 2016-08-17 | 457 | $96.02 | $43.9K | 29,876 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-16 | 2016-08-17 | 3,327 | $97.06 | $322.9K | 1,349,769 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-16 | 2016-08-17 | 20,689 | $96.02 | $1.99M | 1,353,096 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 121 | $98.66 | $11.9K | 30,333 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 2,039 | $97.90 | $199.6K | 30,454 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 5,487 | $98.66 | $541.3K | 1,373,785 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 92,353 | $97.90 | $9.04M | 1,379,272 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2016-06-24 | 2016-06-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-06-09 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2016-05-18 | 2016-05-20 | 3,240 | — | $0 | 3,240 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-18 | 2016-05-19 | 1,314 | $64.02 | $84.1K | 1,471,625 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-18 | 2016-05-19 | 29 | $64.02 | $1.9K | 32,493 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-17 | 2016-05-19 | 3,522 | $65.54 | $230.8K | 1,472,939 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-17 | 2016-05-19 | 78 | $65.54 | $5.1K | 32,522 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-17 | 2016-05-19 | 174 | $64.01 | $11.1K | 32,600 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-17 | 2016-05-19 | 7,866 | $64.01 | $503.5K | 1,476,461 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-16 | 2016-05-19 | 93,700 | $64.68 | $6.06M | 1,488,467 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-16 | 2016-05-19 | 4,140 | $65.47 | $271.0K | 1,484,327 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-16 | 2016-05-19 | 2,069 | $64.68 | $133.8K | 32,865 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-16 | 2016-05-19 | 91 | $65.47 | $6.0K | 32,774 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 4,916 | $19.57 | $96.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 113 | $19.57 | $2.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 265 | $19.57 | $5.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 5,066 | $19.57 | $99.1K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 589 | $20.10 | $11.8K | 113 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 26,697 | $20.10 | $536.6K | 5,066 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 1,392 | $20.10 | $28.0K | 265 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 25,894 | $20.10 | $520.5K | 4,916 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 42 | $20.09 | $844 | 702 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 1,919 | $20.09 | $38.6K | 31,763 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 1,861 | $20.09 | $37.4K | 30,810 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 100 | $20.09 | $2.0K | 1,657 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | J Other | 2015-11-24 | 2016-03-01 | 27,500 | — | $0 | 52,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-23 | 2015-11-24 | 540 | $53.48 | $28.9K | 34,934 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-23 | 2015-11-24 | 24,460 | $53.48 | $1.31M | 1,582,167 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-18 | 2015-11-19 | 696 | $53.16 | $37.0K | 35,474 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-18 | 2015-11-19 | 2,040 | $52.08 | $106.2K | 36,170 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-18 | 2015-11-19 | 92,400 | $52.08 | $4.81M | 1,638,123 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-18 | 2015-11-19 | 31,496 | $53.16 | $1.67M | 1,606,627 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-17 | 2015-11-19 | 1,045 | $51.94 | $54.3K | 38,210 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-17 | 2015-11-19 | 47,323 | $51.94 | $2.46M | 1,730,523 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 56,938 | $18.22 | $1.04M | 32,671 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 3,062 | $18.22 | $55.8K | 1,757 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 58,704 | $18.22 | $1.07M | 33,682 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 1,296 | $18.22 | $23.6K | 744 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 298,929 | $15.70 | $4.69M | 89,609 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 16,071 | $15.70 | $252.3K | 4,819 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 6,805 | $15.70 | $106.8K | 2,040 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 308,195 | $15.70 | $4.84M | 92,386 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 63,596 | $16.32 | $1.04M | 400,581 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 61,684 | $16.32 | $1.01M | 388,538 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 3,316 | $16.32 | $54.1K | 20,890 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 1,404 | $16.32 | $22.9K | 8,845 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 45,112 | $16.75 | $755.6K | 464,177 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 43,755 | $16.75 | $732.9K | 450,222 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 2,352 | $16.75 | $39.4K | 24,206 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 996 | $16.75 | $16.7K | 10,249 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 2,494 | $14.49 | $36.1K | 26,558 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 47,837 | $14.49 | $693.2K | 509,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 1,056 | $14.49 | $15.3K | 11,245 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 46,398 | $14.49 | $672.3K | 493,977 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 2,494 | $17.49 | $43.6K | 26,558 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 46,398 | $17.49 | $811.5K | 493,977 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 47,837 | $17.49 | $836.7K | 509,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 1,056 | $17.49 | $18.5K | 11,245 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-06-08 | 2015-06-08 | 384,968 | $47.94 | $18.46M | 1,777,846 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-06-08 | 2015-06-08 | 8,500 | $47.94 | $407.5K | 39,255 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2015-05-28 | 2015-06-01 | 4,182 | — | $0 | 4,182 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2015-05-26 | 2015-07-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | P Buy deriv | 2015-02-18 | 2015-02-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | P Buy | 2015-02-18 | 2015-02-20 | 25,000 | $3.75 | $93.8K | 80,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 237,245 | $12.29 | $2.92M | 540,375 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 12,755 | $12.29 | $156.8K | 29,052 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 244,600 | $12.29 | $3.01M | 557,126 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 5,400 | $12.29 | $66.4K | 12,301 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 1,276,263 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 1,958,738 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 2,162,814 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 28,180 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 47,755 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 43,249 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2014-11-05 | 2014-11-07 | 8,477 | — | $0 | 8,477 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2014-05-16 | 2014-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 76,531 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,897,959 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,423,469 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 20,408 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 102,041 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 379,592 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,467,595 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 32,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 391,359 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,956,794 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 8,641 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 43,206 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,545 | — | $0 | 14,854 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 98,219 | $14.00 | $1.38M | 777,620 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 18,060 | — | $0 | 32,914 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 251,941 | — | $0 | 276,295 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 335,922 | — | $0 | 612,217 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 67,184 | — | $0 | 679,401 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 5,281 | $14.00 | $73.9K | 41,807 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 3,612 | — | $0 | 36,526 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 346,335 | — | $0 | 631,195 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 5,735 | — | $0 | 6,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 101,264 | $14.00 | $1.42M | 801,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 2,236 | $14.00 | $31.3K | 17,701 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 69,267 | — | $0 | 700,462 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,751 | — | $0 | 284,860 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 1,529 | — | $0 | 15,465 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 7,647 | — | $0 | 13,936 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-16 | 2014-01-17 | 91,449 | $4.86 | $444.4K | 0 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-16 | 2014-01-17 | 4,907 | $4.86 | $23.8K | 0 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-15 | 10,204 | $4.86 | $49.6K | 4,907 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-15 | 189,796 | $4.86 | $922.4K | 91,449 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-14 | 2014-01-15 | 5,000 | $4.87 | $24.4K | 15,111 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-14 | 2014-01-15 | 93,000 | $4.87 | $452.9K | 281,245 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-13 | 2014-01-15 | 6,477 | $4.90 | $31.7K | 20,111 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-13 | 2014-01-15 | 120,479 | $4.90 | $590.3K | 374,245 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-10 | 2014-01-10 | 14,286 | $4.87 | $69.6K | 26,588 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-10 | 2014-01-10 | 265,714 | $4.87 | $1.29M | 494,724 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-09 | 2014-01-10 | 10,204 | $4.87 | $49.7K | 40,874 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-09 | 2014-01-10 | 189,796 | $4.87 | $924.3K | 760,438 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-08 | 2014-01-10 | 231,456 | $4.90 | $1.13M | 950,234 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2014-01-08 | 2014-01-10 | 12,444 | $4.90 | $61.0K | 51,078 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-15 | 2013-07-16 | 84,648 | $5.52 | $467.3K | 1,181,690 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-15 | 2013-07-16 | 4,552 | $5.52 | $25.1K | 63,522 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-12 | 2013-07-16 | 11,877 | $5.54 | $65.8K | 68,074 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-12 | 2013-07-16 | 220,923 | $5.54 | $1.22M | 1,266,338 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-11 | 2013-07-12 | 110,082 | $5.52 | $607.7K | 1,487,261 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-11 | 2013-07-12 | 5,918 | $5.52 | $32.7K | 79,951 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-10 | 2013-07-12 | 58,837 | $5.50 | $323.6K | 1,597,343 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-10 | 2013-07-12 | 3,163 | $5.50 | $17.4K | 85,869 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-05 | 2013-07-08 | 91,070 | $5.48 | $499.1K | 1,656,180 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-05 | 2013-07-08 | 4,897 | $5.48 | $26.8K | 89,032 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-03 | 2013-07-08 | 117,389 | $5.56 | $652.7K | 1,747,250 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-07-03 | 2013-07-08 | 6,311 | $5.56 | $35.1K | 93,929 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-19 | 2013-06-21 | 1,898 | $5.50 | $10.4K | 1,864,639 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-19 | 2013-06-21 | 102 | $5.50 | $561 | 100,240 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-18 | 2013-06-19 | 67,862 | $5.50 | $373.2K | 1,866,537 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-18 | 2013-06-19 | 3,649 | $5.50 | $20.1K | 100,342 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-17 | 2013-06-19 | 50,507 | $5.53 | $279.3K | 1,934,399 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-17 | 2013-06-19 | 2,715 | $5.53 | $15.0K | 103,991 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-11 | 50,865 | $5.50 | $279.8K | 1,984,906 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-11 | 2,735 | $5.50 | $15.0K | 106,706 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-07 | 2013-06-11 | 94,898 | $5.47 | $519.1K | 2,035,771 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2013-06-07 | 2013-06-11 | 5,102 | $5.47 | $27.9K | 109,441 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2013-05-17 | 2013-05-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 25,261 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 1,463,385 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 878,030 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 41,509 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 534,339 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 69,183 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion | 2013-01-30 | 2013-01-31 | 72,646 | — | $0 | 74,034 | SEC↗ |
| LPDX LIPOSCIENCE INC | P Buy | 2013-01-30 | 2013-01-31 | 205,295 | $9.00 | $1.85M | 1,771,347 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion | 2013-01-30 | 2013-01-31 | 1,536,688 | — | $0 | 1,566,052 | SEC↗ |
| LPDX LIPOSCIENCE INC | P Buy | 2013-01-30 | 2013-01-31 | 9,705 | $9.00 | $87.3K | 83,739 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 2,364,705 | $3.31 | $7.83M | 6,323,534 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 52,213 | $3.31 | $172.8K | 139,621 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 2,500 | — | $0 | 57,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 2,500 | — | $0 | 55,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 10,000 | — | $0 | 45,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 12,500 | — | $0 | 32,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 12,500 | — | $0 | 20,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 2,500 | — | $0 | 60,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 10,000 | — | $0 | 65,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise deriv | 2012-09-04 | 2012-09-06 | 2,500 | — | $0 | 62,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 2,500 | $1.30 | $3.3K | 17,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 2,500 | $1.30 | $3.3K | 15,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 12,500 | $1.64 | $20.5K | 55,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 10,000 | $0.79 | $7.9K | 10,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 2,500 | $1.30 | $3.3K | 20,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 10,000 | $1.95 | $19.5K | 30,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 12,500 | $1.62 | $20.3K | 42,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | M Exercise | 2012-09-04 | 2012-09-06 | 2,500 | $1.30 | $3.3K | 12,500 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-27 | 2012-08-27 | 14,612 | $7.98 | $116.6K | 114,543 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-27 | 2012-08-27 | 271,788 | $7.98 | $2.17M | 2,129,669 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-24 | 2012-08-27 | 25,510 | $8.02 | $204.6K | 129,155 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-24 | 2012-08-27 | 474,490 | $8.02 | $3.81M | 2,401,457 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-22 | 2012-08-23 | 2,990 | $7.52 | $22.5K | 154,665 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-22 | 2012-08-23 | 56,610 | $7.52 | $425.7K | 2,875,947 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-21 | 2012-08-23 | 28,469 | $7.50 | $213.5K | 2,932,557 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | S Sale | 2012-08-21 | 2012-08-23 | 1,531 | $7.50 | $11.5K | 157,655 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2012-08-09 | 2012-08-10 | 397,478 | — | $0 | 0 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2012-08-09 | 2012-08-10 | 20,007 | — | $0 | 21,369 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2012-08-09 | 2012-08-10 | 21,369 | — | $0 | 0 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2012-08-09 | 2012-08-10 | 372,149 | — | $0 | 397,478 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2012-08-09 | 2012-08-10 | 372,149 | $1.86 | $692.2K | 2,563,548 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2012-08-09 | 2012-08-10 | 397,478 | $2.05 | $814.8K | 2,961,026 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2012-08-09 | 2012-08-10 | 20,007 | $1.86 | $37.2K | 137,817 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2012-08-09 | 2012-08-10 | 21,369 | $2.05 | $43.8K | 159,186 | SEC↗ |